PHYSICOCHEMICAL BASIS OF THE BUFFERED ACETYLSALICYLIC ACID CONTROVERSY

被引：284

作者：

LEVY, G

HAYES, BA

机构：

来源：

关键词：

D O I：

10.1056/NEJM196005262622102

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1053 / 1058

页数：6

共 57 条

[1] COMPARISON OF BUFFERED AND UNBUFFERED ACETYLSALICYLIC ACID
BATTERMAN, RC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1958, 258 (05) : 213 - 219
[2] BATTERMAN RC, 1956, FED PROC, V15, P398
[3] BOLDT F, 1954, Med Klin, V49, P150
[4] Bradley WB, 1936, AM J DIG DIS, V3, P415
[5] SALICYLATE TOXICITY - THE PROBABLE MECHANISM OF ITS ACTION
CARAVATI, CM
COSGROVE, EF
[J]. ANNALS OF INTERNAL MEDICINE, 1946, 24 (04) : 638 - 642
[6] PLASMA LEVELS AFTER THE ORAL ADMINISTRATION OF ACETYLSALICYLIC ACID AND N-ACETYL-PARA-AMINOPHENOL IN DIFFERENT FORMS TO HUMAN SUBJECTS
CARLO, PE
CAMBOSOS, NM
FEENEY, GC
SMITH, PK
[J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1955, 44 (07): : 396 - 399
[7] THE RELATION BETWEEN INVITRO DISINTEGRATION TIME OF SUGAR-COATED TABLETS AND PHYSIOLOGICAL AVAILABILITY OF RIBOFLAVIN
CHAPMAN, DG
CRISAFIO, R
CAMPBELL, JA
[J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION-SCIENTIFIC EDITION, 1954, 43 (05): : 297 - 304
[8] CLARK BB, 1947, GASTROENTEROLOGY, V9, P461
[9] LABORATORY AND CLINICAL STUDIES WITH BUFFERED AND NONBUFFERED ACETYLSALICYLIC ACID
CRONK, GA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1958, 258 (05) : 219 - 221
[10] Douthwaite AH, 1938, LANCET, V2, P1222